Aranesp Medicare reimbursement increase
Executive Summary
Medicare Part B reimbursement for Amgen's Aranesp will increase 37% from $2.37 to $3.24 per microgram under 2004 hospital prospective payment system 1final rule published Oct. 31. Amgen and Procrit maker J&J have been trading data submissions to Centers for Medicare & Medicaid Services since agency established "functional equivalence" standard for reimbursement of the anemia products (2"The Pink Sheet" Aug. 11, 2003, p. 23). Decision is step in the right direction, Amgen says...